Summary
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Progyny (PGNY) Might be Well Poised for a Surge
Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Are You Looking for a Top Momentum Pick? Why Progyny (PGNY) is a Great Choice
Does Progyny (PGNY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Progyny Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 93 | $2,001.36 | $3,014.32 | $1,012.96 | 50.61% |
| CE Curtis Ellergodt Rothschild Investment LLC | 120 | $2,622.83 | $3,889.44 | $1,266.61 | 48.29% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 415,186 | $7.05M | $13.46M | $6.41M | 90.88% |
 Farallon Capital Farallon Capital Management LLC | 18,000 | $514,980 | $583,740 | $68,760 | 13.35% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 201 | $3,668.14 | $6,518.43 | $2,850.29 | 77.7% |
Progyny Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Glen Santangelo Barclays | 254.54 | $7,595.92 | $8,163.47 | $567.55 | 7.47% |
Progyny Inc. (PGNY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Progyny Inc. ever had a stock split?
Progyny Inc. Profile
| Health Care Technology Industry | Healthcare Sector | David J. Schlanger CEO | NASDAQ (NGS) Exchange | 74340E103 CUSIP |
| US Country | 856 Employees | - Last Dividend | - Last Split | 25 Oct 2019 IPO Date |
Overview
Progyny, Inc. is a pioneering benefits management company in the United States, dedicated to offering fertility and family building benefits solutions. Initially founded as Auxogyn, Inc. in 2008, the company underwent a rebranding to Progyny, Inc. in 2015, marking a significant pivot in its mission to support individuals and couples on their journey to parenthood. With its headquarters in New York, New York, Progyny stands out for its comprehensive approach to fertility benefits, integrating personalized support with access to a selective network of fertility specialists.
Products and Services
- Fertility Benefits Solution
This solution is designed to offer a differentiated benefits plan design that caters to the unique needs of each member. Progyny's approach encompasses personalized concierge-style member support services, ensuring that members receive tailored guidance throughout their fertility journey. Additionally, the company prides itself on its selective network of fertility specialists, aimed at providing high-quality care and improving outcomes for its members.
- Progyny Rx
Understanding the crucial role of medications in fertility treatments, Progyny offers an integrated pharmacy benefits solution, Progyny Rx. This service ensures that members have seamless access to the necessary medications throughout their treatment, aiming to alleviate one of the stressors that individuals and couples face during this challenging time.
- Assistance Service Programs
To further support its members' diverse family building needs, Progyny introduces various assistance service programs. These programs are designed to offer support beyond traditional fertility treatments and can include reimbursement for adoption, surrogacy, doula services, and travel expenses needed to receive medical services. These comprehensive offerings underscore Progyny's commitment to supporting all paths to parenthood.
